Dr. Eytan Stein, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Area of expertise
Acute Myeloid Leukemia
Eytan Stein, MD has run 9 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Myelodysplastic Syndrome
Eytan Stein, MD has run 4 trials for Myelodysplastic Syndrome. Some of their research focus areas include:
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Westchester
Clinical Trials Eytan Stein, MD is currently running
GLB-001
for Acute Myeloid Leukemia
This trial tests a new drug, GLB-001, in patients with certain types of blood cancer that haven't responded to other treatments. The goal is to find out how safe the drug is and what dose works best.
Recruiting
1 award
Phase 1
6 criteria
BTX-A51
for Leukemia
This is an open-label, dose escalation study to evaluate the safety, toxicity, and pharmacokinetics (PK) as well as preliminary efficacy of BTX-A51 capsules in participants with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). The study will be done in three parts. Part 1a (Monotherapy Dose Escalation) of this study is designed to determine the dose-limiting toxicities (DLTs) and maximum tolerated dose (MTD) of orally administered BTX-A51 in up to 35 participants who are evaluable for toxicity. Once the MTD is determined, it is planned that an additional 15 participants will be enrolled in Part 1b (Monotherapy Cohort Expansion) of this study for additional experience with safety and efficacy, and to determine the recommended Phase 2 dose (RP2D) which may or may not be different from the MTD. After determination of MTD and RP2D from Part 1a, Part 1c (Azacitidine Combination Dose Escalation) will enroll up to 30 participants. Continued treatment will be available under this study protocol for up to eight 28-day cycles (Continued Treatment Phase) if the Investigator judges the benefit outweighs the risk. Once BTX-A51 treatment has completed, participants will be contacted by telephone every 3 months for up to 2 years after their last treatment for survival status and anticancer therapy (Overall Survival Follow-up).
Recruiting
1 award
Phase 1
7 criteria
More about Eytan Stein, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Eytan Stein, MD has experience with
- Enasidenib
- Gilteritinib
- Ivosidenib
- Venetoclax
- Azacitidine
- E7820
Breakdown of trials Eytan Stein, MD has run
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Recurrence
Acute Myeloblastic Leukemia
Clonal Cytopenia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eytan Stein, MD specialize in?
Eytan Stein, MD focuses on Acute Myeloid Leukemia and Myelodysplastic Syndrome. In particular, much of their work with Acute Myeloid Leukemia has involved FLT3 positive patients, or patients who are IDH positive.
Is Eytan Stein, MD currently recruiting for clinical trials?
Yes, Eytan Stein, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Eytan Stein, MD has studied deeply?
Yes, Eytan Stein, MD has studied treatments such as Enasidenib, Gilteritinib, Ivosidenib.
What is the best way to schedule an appointment with Eytan Stein, MD?
Apply for one of the trials that Eytan Stein, MD is conducting.
What is the office address of Eytan Stein, MD?
The office of Eytan Stein, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.